Breaking News

WuXi Biologics Co. Removed from U.S. Unverified List

CRDMO's subsidiary located in Wuxi city was removed from the Unverified List (UVL) by the U.S. Department of Commerce effective October 7, 2022.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WuXi Biologics, a global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its subsidiary WuXi Biologics Co., Ltd. located in Wuxi city was removed from the Unverified List (UVL) by the U.S. Department of Commerce, effective October 7, 2022.   In February 2022, two subsidiaries of WuXi Biologics, WuXi Biologics Co., Ltd. and WuXi Biologics (Shanghai) Co., Ltd., were placed on the UVL due to delayed verifications required for the receipt of certain products e...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters